Correlation Between AN2 Therapeutics and Apexigen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Apexigen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Apexigen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Apexigen, you can compare the effects of market volatilities on AN2 Therapeutics and Apexigen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Apexigen. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Apexigen.

Diversification Opportunities for AN2 Therapeutics and Apexigen

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between AN2 and Apexigen is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Apexigen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apexigen and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Apexigen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apexigen has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Apexigen go up and down completely randomly.

Pair Corralation between AN2 Therapeutics and Apexigen

Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 2.04 times more return on investment than Apexigen. However, AN2 Therapeutics is 2.04 times more volatile than Apexigen. It trades about 0.0 of its potential returns per unit of risk. Apexigen is currently generating about -0.1 per unit of risk. If you would invest  641.00  in AN2 Therapeutics on August 31, 2024 and sell it today you would lose (474.00) from holding AN2 Therapeutics or give up 73.95% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy8.56%
ValuesDaily Returns

AN2 Therapeutics  vs.  Apexigen

 Performance 
       Timeline  
AN2 Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in AN2 Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, AN2 Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Apexigen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apexigen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Apexigen is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

AN2 Therapeutics and Apexigen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AN2 Therapeutics and Apexigen

The main advantage of trading using opposite AN2 Therapeutics and Apexigen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Apexigen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apexigen will offset losses from the drop in Apexigen's long position.
The idea behind AN2 Therapeutics and Apexigen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data